1Elonen E,Almqvist A,Huninen A,et al.Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trail of the Finnish Leukemia Group[].Leukemia.1998
2Takemoto Y,Sampi K,Kurashi Y,et al.A prospective randomized trial of KRN8602 and cytosine arabinoside vs daunorubicin and cytosine arabinosisde in adult patients with newly diagnosed acute myelogenous leukemia.The KRN8602 Leukemia Study Group[].International Journal of Hematology.1999
3Chen,ZX,Xue YQ,Zhang R,et al.A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia[].Blood.1991
4Letendre L,Noel P,Litzow MR,et al.Treatment of acute myelogenous leukemia in the older patient with attenuated high-dose ara-C[].American Journal of Clinical Oncology.1998
5Buchner T,Hiddemann W,Wormann B,et al.Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trail by the German AML Cooperative Group[].Blood.1999
6Usui N,Dobashi N,Kobayashi T,et al.Role of daunorubicin in the induction therapy for adult acute myeloid leukemia[].Journal of Clinical Oncology.1998
7Caron PC,Dumont L,Scheinberg DA.Supersaturating infusional humanized anti-CD33 monoclonal antiboby HuM195 in myelogenous leukemia[].Clinical Cancer Research.1998
8Estey EH.New agents for the treatment of acute myelogenous leukemia: focus on topotecan and retinoids[].Leukemia.1998
9Mandelli F,Diverio D,Avvisati G,et al.Molecula remission in PML/ RARα positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin(AIDA) therapy[].Blood.1997
10Larrea L,Mart ez JA,Sanz GF,et al.Carboplatin plus cytarabine in the treatment of high-risk acute myeloblastic leukemia[].Leukemia.1999
